New immunotherapy targeting blood-clotting protein
A team has developed an antibody that blocks the inflammatory and oxidative activity of fibrin, which contributes to neurodegeneration in the brain, without compromising the protein’s clotting function.
Original source: https://www.sciencedaily.com/releases/2018/10/181015132957.htm
